AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
BCL-X AND THE APOPTOTIC MACHINERY OF LYMPHOMA-CELLS
Authors: XERRI L HASSOUN J DEVILARD E BIRNBAUM D BIRG F
Citation: L. Xerri et al., BCL-X AND THE APOPTOTIC MACHINERY OF LYMPHOMA-CELLS, Leukemia & lymphoma, 28(5-6), 1998, pp. 451-458
ROLE OF INDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULT LYMPHOBLASTIC LYMPHOMA - A REPORT ON 62 PATIENTS FROM A SINGLE-CENTER
Authors: BOUABDALLAH R XERRI L BARDOU VJ STOPPA AM BLAISE D SAINTY D MARANINCHI D GASTAUT JA
Citation: R. Bouabdallah et al., ROLE OF INDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULT LYMPHOBLASTIC LYMPHOMA - A REPORT ON 62 PATIENTS FROM A SINGLE-CENTER, Annals of oncology, 9(6), 1998, pp. 619-625
RUPTURE OF THE SPLEEN REVEALING WALDENSTR OMS-DISEASE
Authors: QUILICHINI R POUTSLAJUS P BRECQUEVILLE JM XERRI L ZANLUCCA S BAUME D
Citation: R. Quilichini et al., RUPTURE OF THE SPLEEN REVEALING WALDENSTR OMS-DISEASE, La Presse medicale, 27(4), 1998, pp. 160-160
ANALYSIS OF BAX EXPRESSION IN HUMAN TISSUES USING THE ANTI-BAX, 4F11 MONOCLONAL-ANTIBODY ON PARAFFIN SECTIONS
Authors: PENAULTLLORCA F BOUABDALLAH R DEVILARD E CHARTONBAIN MC HASSOUN J BIRG F XERRI L
Citation: F. Penaultllorca et al., ANALYSIS OF BAX EXPRESSION IN HUMAN TISSUES USING THE ANTI-BAX, 4F11 MONOCLONAL-ANTIBODY ON PARAFFIN SECTIONS, Pathology research and practice, 194(7), 1998, pp. 457-464
GUIDELINES FOR DIAGNOSIS IN HEMATOPATHOLOGY - FOR A RATIONALIZATION OF HISTOLOGICAL, PHENOTYPIC AND GENOTYPIC DIAGNOSIS
Authors: XERRI L BROUSSE N
Citation: L. Xerri et N. Brousse, GUIDELINES FOR DIAGNOSIS IN HEMATOPATHOLOGY - FOR A RATIONALIZATION OF HISTOLOGICAL, PHENOTYPIC AND GENOTYPIC DIAGNOSIS, Annales de pathologie, 18(4), 1998, pp. 343-360
SENSITIVITY TO FAS-MEDIATED APOPTOSIS IS NULL OR WEAK IN B-CELL NON-HODGKINS-LYMPHOMAS AND IS MODERATELY INCREASED BY CD40 LIGATION
Authors: XERRI L BOUABDALLAH R DEVILARD E HASSOUN J STOPPA AM BIRG F
Citation: L. Xerri et al., SENSITIVITY TO FAS-MEDIATED APOPTOSIS IS NULL OR WEAK IN B-CELL NON-HODGKINS-LYMPHOMAS AND IS MODERATELY INCREASED BY CD40 LIGATION, British Journal of Cancer, 78(2), 1998, pp. 225-232
PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS
Authors: GISSELBRECHT C GAULARD P LEPAGE E COIFFIER B BRIERE J HAIOUN C CAZALSHATEM D BOSLY A XERRI L TILLY H BERGER F BOUHABDALLAH R DIEBOLD J
Citation: C. Gisselbrecht et al., PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS, Blood, 92(1), 1998, pp. 76-82
FAS LIGAND IS NOT ONLY EXPRESSED IN IMMUNE PRIVILEGED HUMAN ORGANS BUT IS ALSO COEXPRESSED WITH FAS IN VARIOUS EPITHELIAL TISSUES
Authors: XERRI L DEVILARD E HASSOUN J MAWAS C BIRG F
Citation: L. Xerri et al., FAS LIGAND IS NOT ONLY EXPRESSED IN IMMUNE PRIVILEGED HUMAN ORGANS BUT IS ALSO COEXPRESSED WITH FAS IN VARIOUS EPITHELIAL TISSUES, Journal of clinical pathology-Molecular pathology, 50(2), 1997, pp. 87-91
MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS FREQUENTLY EXPRESS FAS LIGAND BUT DISPLAY A DIFFERENT SENSITIVITY TO FAS-MEDIATED APOPTOSIS
Authors: XERRI L DEVILARD E HASSOUN J HADDAD P BIRG F
Citation: L. Xerri et al., MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS FREQUENTLY EXPRESS FAS LIGAND BUT DISPLAY A DIFFERENT SENSITIVITY TO FAS-MEDIATED APOPTOSIS, Leukemia, 11(11), 1997, pp. 1868-1877
INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED BLOOD STEM-CELL SUPPORT FOR UNTREATED POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA
Authors: STOPPA AM BOUABDALLAH R CHABANNON C NOVAKOVITCH G VEY N CAMERLO J BLAISE D XERRI L RESBEUT M DISTEFANO D BARDOU VJ GASTAUT JA MARANINCHI D
Citation: Am. Stoppa et al., INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED BLOOD STEM-CELL SUPPORT FOR UNTREATED POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 15(5), 1997, pp. 1722-1729
CLEAR-CELL SARCOMA OF THE KIDNEY - A RELA PSE AFTER 10 YEARS WITHOUT RECURRENCE
Authors: CHARAFE E PENAULTLLORCA F MATHOULINPORTIER MP BLADOU F DELPERO JR PRIMEGUITTON C VIEILLEFOND A XERRI L HASSOUN J
Citation: E. Charafe et al., CLEAR-CELL SARCOMA OF THE KIDNEY - A RELA PSE AFTER 10 YEARS WITHOUT RECURRENCE, Annales de pathologie, 17(6), 1997, pp. 400-402
CYSTEINE PROTEASE CPP32, BUT NOT ICH1-L, IS EXPRESSED IN GERMINAL CENTER B-CELLS AND THEIR NEOPLASTIC COUNTERPARTS
Authors: XERRI L DEVILARD E AYELLO C BROUSSET P REED JC EMILE JF HASSOUN J PARMENTIER S BIRG F
Citation: L. Xerri et al., CYSTEINE PROTEASE CPP32, BUT NOT ICH1-L, IS EXPRESSED IN GERMINAL CENTER B-CELLS AND THEIR NEOPLASTIC COUNTERPARTS, Human pathology, 28(8), 1997, pp. 912-921
IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS
Authors: XERRI L DEVILARD E HASSOUN J OLIVE D BIRG F
Citation: L. Xerri et al., IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS, Journal of pathology, 183(2), 1997, pp. 182-187
IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS
Authors: XERRI L DEVILARD E HASSOUN J BOUABDALLAH R STOPPA AM OLIVE D BIRG F
Citation: L. Xerri et al., IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS, Blood, 90(10), 1997, pp. 3966-3966
SENSITIVITY TO FAS-MEDIATED APOPTOSIS IS NULL OR WEAK IN NEOPLASTIC-CELLS FROM MOST SUBTYPES OF B-CELL NON-HODGKINS-LYMPHOMAS AND IS ONLY MODERATELY INCREASED BY CD40 LIGATION
Authors: XERRI L DEVILARD E HASSOUN J BOUABDALLAH R BIRG F
Citation: L. Xerri et al., SENSITIVITY TO FAS-MEDIATED APOPTOSIS IS NULL OR WEAK IN NEOPLASTIC-CELLS FROM MOST SUBTYPES OF B-CELL NON-HODGKINS-LYMPHOMAS AND IS ONLY MODERATELY INCREASED BY CD40 LIGATION, Blood, 90(10), 1997, pp. 323-323
PROGNOSTIC VALUE OF SUBCLASSIFICATION OF DIFFUSE LARGE B-CELL LYMPHOMAS ACCORDING TO THE KIEL CLASSIFICATION - A GELA STUDY ON 1487 PATIENTS
Authors: MOREL P XERRI L COJEAN I GAULARD P TILLY H BESUSCHIO S CASASNOVAS O DIEBOLD J
Citation: P. Morel et al., PROGNOSTIC VALUE OF SUBCLASSIFICATION OF DIFFUSE LARGE B-CELL LYMPHOMAS ACCORDING TO THE KIEL CLASSIFICATION - A GELA STUDY ON 1487 PATIENTS, Blood, 90(10), 1997, pp. 1500-1500
INTENSIVE SEQUENTIAL CHEMOTHERAPY (ISC) WITH REPEATED BLOOD STEM-CELLSUPPORT FOR UNTREATED POOR-PROGNOSIS NON-HODGKINS-LYMPHOMAS (NHLS)
Authors: BOUABDALLAH R STOPPA AM COSO D CHABANNON C XERRI L GASTAUT JA MARANINCHI D
Citation: R. Bouabdallah et al., INTENSIVE SEQUENTIAL CHEMOTHERAPY (ISC) WITH REPEATED BLOOD STEM-CELLSUPPORT FOR UNTREATED POOR-PROGNOSIS NON-HODGKINS-LYMPHOMAS (NHLS), Blood, 90(10), 1997, pp. 1697-1697
EXPRESSION OF FGF1 AND FGFR1 IN HUMAN-MELANOMA TISSUES
Authors: XERRI L BATTYANI Z GROB JJ PARC P HASSOUN J BONERANDI JJ BIRNBAUM D
Citation: L. Xerri et al., EXPRESSION OF FGF1 AND FGFR1 IN HUMAN-MELANOMA TISSUES, Melanoma research, 6(3), 1996, pp. 223-230
LEUKOPENIA, THROMBOCYTOPENIA, AND ACUTE AUTOIMMUNE HEMOLYTIC-ANEMIA ASSOCIATED WITH AN UNUSUAL (TYPE-2 4) HODGKINS-DISEASE - CASE-REPORT/
Authors: COSTELLO RT XERRI L BOUABDALLAH R GASTAUT JA SAINTY D
Citation: Rt. Costello et al., LEUKOPENIA, THROMBOCYTOPENIA, AND ACUTE AUTOIMMUNE HEMOLYTIC-ANEMIA ASSOCIATED WITH AN UNUSUAL (TYPE-2 4) HODGKINS-DISEASE - CASE-REPORT/, American journal of hematology, 52(4), 1996, pp. 333-334
INSULIN-INDUCED LIPOATROPHY IN TYPE-I DIABETES - A POSSIBLE TUMOR NECROSIS FACTOR-ALPHA-MEDIATED DEDIFFERENTIATION OF ADIPOCYTES
Authors: ATLANGEPNER C BONGRAND P FARNARIER C XERRI L CHOUX R GAUTHIER JF BRUE T VAGUE P GROB JJ VIALETTES B
Citation: C. Atlangepner et al., INSULIN-INDUCED LIPOATROPHY IN TYPE-I DIABETES - A POSSIBLE TUMOR NECROSIS FACTOR-ALPHA-MEDIATED DEDIFFERENTIATION OF ADIPOCYTES, Diabetes care, 19(11), 1996, pp. 1283-1285
MOLECULAR ANALYSIS OF THE NPM-ALK REARRANGEMENT IN HODGKINS-DISEASE
Authors: XERRI L PARC P HASSOUN J BIRNBAUM D
Citation: L. Xerri et al., MOLECULAR ANALYSIS OF THE NPM-ALK REARRANGEMENT IN HODGKINS-DISEASE, Journal of pathology, 178(2), 1996, pp. 128-132
SYNTHESIS AND ANTIMICROBIAL EVALUATION OF ETA-CARBAMOYLMETHYL-PENAM-1,1-DIOXIDE-3-CARBOXYLIC ACID
Authors: GAVIRAGHI G PERBONI A TAMBURINI B XERRI L SALVATORI A SPADONI G TARZIA G
Citation: G. Gaviraghi et al., SYNTHESIS AND ANTIMICROBIAL EVALUATION OF ETA-CARBAMOYLMETHYL-PENAM-1,1-DIOXIDE-3-CARBOXYLIC ACID, Il Farmaco, 51(7), 1996, pp. 535-538
PREDOMINANT EXPRESSION OF THE LONG ISOFORM OF BCL-X (BCL-XL) IN HUMANLYMPHOMAS
Authors: XERRI L PARC P BROUSSET P SCHLAIFER D HASSOUN J REED JC KRAJEWSKI S BIRNBAUM D
Citation: L. Xerri et al., PREDOMINANT EXPRESSION OF THE LONG ISOFORM OF BCL-X (BCL-XL) IN HUMANLYMPHOMAS, British Journal of Haematology, 92(4), 1996, pp. 900-906
PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS
Authors: GISSELBRECHT C GAULARD P LEPAGE E COIFFIER B BRIERE FJ HAIOUN C CAZALS D BOSLY A XERRI L TILLY H BERGER F BOUHABDALLAH R DIEBOLD J
Citation: C. Gisselbrecht et al., PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS, Blood, 88(10), 1996, pp. 1159-1159
EPSTEIN-BARR-VIRUS ASSOCIATED LYMPHOPROLI FERATION AFTER RENAL-TRANSPLANTATION - CONTRIBUTION OF GENOTYPIC ANALYSIS
Authors: DUSSOL B BERNARD O XERRI L STOPPA AM BRUNET P MARANINCHI D BERLAND Y
Citation: B. Dussol et al., EPSTEIN-BARR-VIRUS ASSOCIATED LYMPHOPROLI FERATION AFTER RENAL-TRANSPLANTATION - CONTRIBUTION OF GENOTYPIC ANALYSIS, La Presse medicale, 24(22), 1995, pp. 1033-1035
Risultati: 1-25 | 26-38